Triple negative breast cancer (TNBC) defines a clinical subset of breast cancer negative for estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor type 2 (HER2). This evidence concerns the gene ESR1 and breast carcinoma.